Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation

被引:289
作者
Niimura, F
Labosky, PA
Kakuchi, J
Okubo, S
Yoshida, H
Oikawa, T
Ichiki, T
Naftilan, AJ
Fogo, A
Inagami, T
Hogan, BLM
Ichikawa, I
机构
[1] VANDERBILT UNIV,SCH MED,DEPT PEDIAT,NASHVILLE,TN 37232
[2] VANDERBILT UNIV,SCH MED,DEPT CELL BIOL,NASHVILLE,TN 37232
[3] VANDERBILT UNIV,SCH MED,DEPT PATHOL,NASHVILLE,TN 37232
[4] VANDERBILT UNIV,SCH MED,DEPT BIOCHEM,NASHVILLE,TN 37232
[5] VANDERBILT UNIV,SCH MED,DEPT MED,NASHVILLE,TN 37232
[6] VANDERBILT UNIV,SCH MED,HOWARD HUGHES MED INST,NASHVILLE,TN 37232
关键词
nephrosclerosis; hypotension; platelet-derived growth factor; transforming growth factor;
D O I
10.1172/JCI118366
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Elevated levels of endogenous angiotensin can cause hypertensive nephrosclerosis as a result of the potent vasopressor action of the peptide, We have produced by gene targeting mice homozygous for a null mutation in the angiotensinogen gene (Atg(-/-)). Postnatally, Atg(-/-) animals show a modest delay in glomerular maturation, Although Atg(-/-) animals are hypotensive by 7 wk of age, they develop, by 3 wk of age, pronounced lesions in the renal cortex, similar to those of hypertensive nephrosclerosis, In addition, the papillae of homozygous mutant kidneys are reduced in size. These lesions are accompanied by local up-regulation of PDGF-B and TGF-beta 1 mRNA in the cortex and down-regulation of PDGF-A mRNA in the papilla, The study demonstrates an important requirement for angiotensin in achieving and maintaining the normal morphology of the kidney. The mechanism through which angiotensin maintains the volume homeostasis in mammals includes promotion of the maturational growth of the papilla.
引用
收藏
页码:2947 / 2954
页数:8
相关论文
共 39 条
[1]   THERAPEUTIC ADVANTAGE OF CONVERTING ENZYME-INHIBITORS IN ARRESTING PROGRESSIVE RENAL-DISEASE ASSOCIATED WITH SYSTEMIC HYPERTENSION IN THE RAT [J].
ANDERSON, S ;
RENNKE, HG ;
BRENNER, BM .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (06) :1993-2000
[2]   CONTROL OF GLOMERULAR HYPERTENSION LIMITS GLOMERULAR INJURY IN RATS WITH REDUCED RENAL MASS [J].
ANDERSON, S ;
MEYER, TW ;
RENNKE, HG ;
BRENNER, BM .
JOURNAL OF CLINICAL INVESTIGATION, 1985, 76 (02) :612-619
[3]  
[Anonymous], 1994, MANIPULATING MOUSE E
[4]   RENIN-ANGIOTENSIN SYSTEM INVOLVEMENT IN PRESSURE-OVERLOAD CARDIAC-HYPERTROPHY IN RATS [J].
BAKER, KM ;
CHERNIN, MI ;
WIXSON, SK ;
ACETO, JF .
AMERICAN JOURNAL OF PHYSIOLOGY, 1990, 259 (02) :H324-H332
[5]   LONG-TERM BENEFITS OF ANGIOTENSIN-CONVERTING ENZYME-INHIBITOR THERAPY IN PATIENTS WITH SEVERE IMMUNOGLOBULIN A NEPHROPATHY - A COMPARISON TO PATIENTS RECEIVING TREATMENT WITH OTHER ANTIHYPERTENSIVE AGENTS AND TO PATIENTS RECEIVING NO THERAPY [J].
CATTRAN, DC ;
GREENWOOD, C ;
RITCHIE, S .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1994, 23 (02) :247-254
[6]  
CLOUSTON W M, 1988, Genomics, V2, P240, DOI 10.1016/0888-7543(88)90008-0
[7]   CILAZAPRIL PREVENTS THE DEVELOPMENT OF CARDIAC-HYPERTROPHY AND THE DECREASE OF CORONARY VASCULAR RESERVE IN SPONTANEOUSLY HYPERTENSIVE RATS [J].
CLOZEL, JP ;
HEFTI, F .
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1988, 11 (05) :568-572
[8]   DIABETES-ASSOCIATED MESENTERIC VASCULAR HYPERTROPHY IS ATTENUATED BY ANGIOTENSIN-CONVERTING ENZYME-INHIBITION [J].
COOPER, ME ;
RUMBLE, J ;
KOMERS, R ;
HECHENG, D ;
JANDELEIT, K ;
SHEUNGTO, C .
DIABETES, 1994, 43 (10) :1221-1228
[9]   CULTURED ENDOTHELIAL-CELLS PRODUCE A PLATELET-DERIVED GROWTH FACTOR-LIKE PROTEIN [J].
DICORLETO, PE ;
BOWENPOPE, DF .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (07) :1919-1923
[10]   IMPORTANCE OF ANGIOGENIC ACTION OF ANGIOTENSIN-II IN THE GLOMERULAR GROWTH OF MATURING KIDNEYS [J].
FOGO, A ;
YOSHIDA, Y ;
YARED, A ;
ICHIKAWA, I .
KIDNEY INTERNATIONAL, 1990, 38 (06) :1068-1074